Angiolink Corporation

About:

Angiolink privately held medical device company focused on developing innovative wound closure solutions for vascular procedures.

Website: http://www.angiolink.com/

Top Investors: Bioventures Investors, Boston Financial & Equity Corporation, IDP Industrial Development Partners, JHK Investments

Description:

Angiolink Corporation offers EVS vascular closure system, an arterial stapling device for use in closing holes and punctures made in arteries in connection with the catheter-based surgical procedures, such as angioplasty and angiograms.

Total Funding Amount:

$24.2M

Headquarters Location:

Taunton, Massachusetts, United States

Founded Date:

1999-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2003-09-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai